MedTrace Logo

Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.

NCT03161444 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 354

Last updated 2022-03-21

No results posted yet for this study

Summary

This study will estimate the cumulative incidence of Zika infection at the end of the first epidemic in the French West Indies in a sample of patients followed for HIV infection.

Conditions

  • HIV Infections
  • Zika Virus Infection

Interventions

OTHER

Biological sample collection

A blood sample collection for the study will be taken to each participant Each subject enrolled must have previously participated to the study CHIKVIH.

Sponsors & Collaborators

  • University Hospital of Guadeloupe

    collaborator UNKNOWN

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Andre CABIE, MD · University Hospital of Martinique

  • Bruno HOEN, MD · University Hospital of Gaudeloupe

  • Andre CABIE, MD · University Hospital of Martinique

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-21
Primary Completion
2019-08-10
Completion
2020-03-02

Countries

  • Guadeloupe
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03161444 on ClinicalTrials.gov